TriSalus Life Sciences, Inc. (TLSI) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - TLSI

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth53.41%

5Y CAGR52.72%

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth166.09%

5Y CAGR10.99%

10Y CAGRN/A

Equity

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	53.4%	56.2%	53.9%	52.7%	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	59.0%	54.1%	51.9%	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	49.3%	48.4%	50.5%	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	47.6%	51.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	54.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - TLSI

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on TriSalus Life Sciences, Inc.

Compare with peers

Explore

Growth Analysis - TLSI

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on TriSalus Life Sciences, Inc.

Compare with peers

Explore